Insulin resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and a normal or abnormal coronary angiogram

Wynn Institute for Metabolic Research, London, England, United Kingdom.

OBJECTIVES. The aim of this study was to compare metabolic risk factors in men with anginal chest pain and a normal or abnormal coronary angiogram with those in healthy men. BACKGROUND. Risk factors for coronary heart disease, including lipoprotein abnormalities, hypertension and adiposity, may be metabolically interlinked, with insulin resistance and hyperinsulinemia being pivotal to these disturbances. METHODS. Glucose and insulin metabolism, lipids and lipoproteins, hemostasis, blood pressure and body fat distribution were measured in 77 nonobese middle-aged men who had anginal chest pain (39 with an abnormal coronary angiogram and 38 with no detectable angiographic abnormality) and were compared with those of 40 healthy men of similar age and body mass index. RESULTS. Patients with chest pain had higher insulin responses to an intravenous glucose challenge, lower insulin sensitivity, lower high density lipoprotein (HDL) and subfraction 2 cholesterol, lower apolipoprotein AI, higher triglycerides, greater android fat and higher systolic blood pressure at rest compared with levels in healthy control subjects (p < 0.05). Those with an abnormal coronary angiogram had lower tissue plasminogen activator levels, higher plasminogen activator inhibitor 1 levels and more android fat than did those with a normal angiogram (p < 0.05). Insulin sensitivity correlated positively with HDL (p < 0.05) and subfraction 2 (p < 0.001) cholesterol and negatively with triglycerides (p < 0.01), android fat proportion (p < 0.01) and systolic blood pressure (p < 0.05), whereas insulin response showed converse correlations. CONCLUSIONS. These findings provide new evidence of the central role of insulin resistance and hyperinsulinemia in the development of risk factors associated with coronary heart disease.

This article has been cited by other articles:

				N. G. Suskin, G. Heigenhauser, R. Afzal, D. Finegood, H. C. Gerstein, and R. S. McKelvie The effects of exercise training on insulin resistance in patients with coronary artery disease European Journal of Cardiovascular Prevention & Rehabilitation, December 1, 2007; 14(6): 803 - 808. [Abstract] [Full Text] [PDF]

				J. Frohlich and M. Dobiasova Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography Clin. Chem., November 1, 2003; 49(11): 1873 - 1880. [Abstract] [Full Text] [PDF]

				S. Takata, A. Shimakura, S. Sakagami, Y. Nakamura, H. Ohkuwa, K.-i. Kobayashi, and H. Nagai Enhanced Insulin Response to Oral Glucose Load in Patients with Angina Pectoris Associated with ST Segment Elevation in the Absence of Epicardial Coronary Arterial Obstruction Angiology, September 1, 1998; 49(9): 815 - 826. [Abstract] [PDF]

				I. Toft, K. H. Bonaa, O. C. Ingebretsen, A. Nordoy, and T. Jenssen Fibrinolytic Function After Dietary Supplementation With {omega}3 Polyunsaturated Fatty Acids Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 814 - 819. [Abstract] [Full Text]

				T. K. Nordt, K. Kornas, K. Peter, S. Fujii, B. E. Sobel, W. Kubler, and C. Bode Attenuation by Gemfibrozil of Expression of Plasminogen Activator Inhibitor Type 1 Induced by Insulin and its Precursors Circulation, February 4, 1997; 95(3): 677 - 683. [Abstract] [Full Text]

				H. Taegtmeyer Insulin Resistance and Atherosclerosis : Common Roots for Two Common Diseases? Circulation, May 15, 1996; 93(10): 1777 - 1779. [Full Text]